Neurocrine Biosciences, Inc. (NBIX) Tops Q2 EPS by 2c
Tweet Send to a FriendGet Alerts NBIX Hot Sheet
Price: $13.04 +2.60%
Revenue Growth %: -93.8%
Financial Fact:
Total revenues: 730K
Today's EPS Names:
ANF, DXLG, FL, More
Revenue Growth %: -93.8%
Financial Fact:
Total revenues: 730K
Today's EPS Names:
ANF, DXLG, FL, More
Trade NBIX Now!
Neurocrine Biosciences, Inc. (NASDAQ: NBIX) reported Q2 EPS of ($0.01), $0.02 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $10.6 million versus the consensus estimate of $11 million.
For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
For earnings history and earnings-related data on Neurocrine Biosciences, Inc. (NBIX) click here.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Abercrombie & Fitch Co. (ANF) Misses Q1 EPS by 4c; Guides FY Below Views
- salesforce.com, Inc. (CRM) Reports In-Line Q1 EPS; Issues In-Line Q2, FY14 Outlook
- Neurocrine Biosciences to Present At The Deutsche Bank 38th Annual dbAccess Health Care Conference
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
